[HTML][HTML] Booster of mRNA-1273 vaccine reduces SARS-CoV-2 Omicron escape from neutralizing antibodies

NA Doria-Rose, X Shen, SD Schmidt, S O'Dell… - MedRxiv, 2021 - medrxiv.org
The Omicron variant of SARS-CoV-2 is raising concerns because of its increased
transmissibility and potential for reduced susceptibility to antibody neutralization. To assess …

[HTML][HTML] Booster of mRNA-1273 strengthens SARS-CoV-2 Omicron neutralization

NA Doria-Rose, X Shen, SD Schmidt, S O'Dell… - MedRxiv, 2021 - ncbi.nlm.nih.gov
The Omicron variant of SARS-CoV-2 is raising concerns because of its increased
transmissibility and potential for reduced susceptibility to antibody neutralization. To assess …

SARS-CoV-2 Omicron variant neutralization after mRNA-1273 booster vaccination

R Pajon, NA Doria-Rose, X Shen… - … England Journal of …, 2022 - Mass Medical Soc
Omicron Neutralization and mRNA-1273 Boosters Neutralization of the omicron variant was
assessed in serum samples obtained from persons who had received an mRNA-1273 …

Considerable escape of SARS-CoV-2 variant Omicron to antibody neutralization

D Planas, N Saunders, P Maes, F Guivel-Benhassine… - BioRxiv, 2021 - biorxiv.org
The SARS-CoV-2 Omicron variant was first identified in November 2021 in Botswana and
South Africa,. It has in the meantime spread to many countries and is expected to rapidly …

[HTML][HTML] SARS-CoV-2 Omicron neutralization by therapeutic antibodies, convalescent sera, and post-mRNA vaccine booster

S Lusvarghi, SD Pollett, SN Neerukonda, W Wang… - BioRxiv, 2021 - ncbi.nlm.nih.gov
The rapid spread of the highly contagious Omicron variant of SARS-CoV-2 along with its
high number of mutations in the spike gene has raised alarm about the effectiveness of …

Variable loss of antibody potency against SARS-CoV-2 B. 1.1. 529 (Omicron)

DJ Sheward, C Kim, RA Ehling, A Pankow, XC Dopico… - BioRxiv, 2021 - biorxiv.org
The recently-emerged SARS-CoV-2 B. 1.1. 529 variant (Omicron) is spreading rapidly in
many countries, with a spike that is highly diverged from the pandemic founder, raising fears …

[HTML][HTML] mRNA-1273 Vaccine-elicited neutralization of SARS-CoV-2 Omicron in adolescents and children

B Girard, JE Tomassini, W Deng, M Maglinao, H Zhou… - medRxiv, 2022 - ncbi.nlm.nih.gov
Background The highly transmissible severe acute respiratory syndrome coronavirus-2
(SARS-CoV-2) Omicron variant is a global concern. This study assessed the neutralization …

[HTML][HTML] mRNA-1273 and BNT162b2 mRNA vaccines have reduced neutralizing activity against the SARS-CoV-2 omicron variant

VV Edara, KE Manning, M Ellis, L Lai, KM Moore… - Cell Reports …, 2022 - cell.com
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) omicron variant
emerged in November 2021 and consists of several mutations within the spike. We use …

[HTML][HTML] Enhanced antibody responses in fully vaccinated individuals against pan-SARS-CoV-2 variants following Omicron breakthrough infection

HW Jeong, SM Kim, MK Jung, JY Noh, JS Yoo… - Cell Reports …, 2022 - cell.com
Omicron has become the globally dominant severe acute respiratory syndrome coronavirus
2 (SARS-CoV-2) variant, creating additional challenges due to its ability to evade …

[HTML][HTML] mRNA booster immunization elicits potent neutralizing serum activity against the SARS-CoV-2 Omicron variant

H Gruell, K Vanshylla, P Tober-Lau, D Hillus… - Nature medicine, 2022 - nature.com
The Omicron variant of SARS-CoV-2 is causing a rapid increase in infections across the
globe. This new variant of concern carries an unusually high number of mutations in key …